Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis

G. M. Murraya Department of Rheumatology, Bristol Royal Hospital for Children, Bristol, UKView further author information

, MB, BCh, BaO, MRCPI, FRACP,

N. Griffithb Department of Ophthalmology Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UKView further author information

, MBBS, BSc,

P. Sinnappurajara Department of Rheumatology, Bristol Royal Hospital for Children, Bristol, UKView further author information

, MBBS ,DCH,

D. A. Al Julandania Department of Rheumatology, Bristol Royal Hospital for Children, Bristol, UKView further author information

, MD,

S. L. N. Clarkea Department of Rheumatology, Bristol Royal Hospital for Children, Bristol, UK;c MRC Integrative Epidemiology Unit and School of Population Health Sciences, University of Bristol, Bristol, UKView further author information

, BSc, BM BCh, PhD, MRCPCH,

D. P. Hawleyd Department of Rheumatology Sheffield Children’s NHS Foundation Trust, Sheffield, UKView further author information

, BMBS,

J. Choib Department of Ophthalmology Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK;d Department of Rheumatology Sheffield Children’s NHS Foundation Trust, Sheffield, UKView further author information

, FRCOphth,

C. M. Gulye Department of Ophthalmology University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UKView further author information

, MBChB &

Athimalaipet V. Ramanana Department of Rheumatology, Bristol Royal Hospital for Children, Bristol, UK;f Bristol Medical School: Translational Health Sciences, University of Bristol, Bristol, UKCorrespondence[email protected]
View further author information

, FRCPCH, FRCP show all

Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date